About the Company
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on DBV Technologies S.A.
Why DBV Technologies SA Plummeted and Aimmune Therapeutics Inc ... - Nasdaq
What happened DBV Technologies (NASDAQ: DBVT) is down 45% at 12:48 p.m. EDT after announcing that its peanut allergy treatment, Viaskin Peanut, failed -- albeit not by much -- a phase 3 trial.
DBV Technologies SA (DBVT) Fell Out Of Favor With Hedge Funds
DBV Technologies SA (NASDAQ: DBVT) was in 5 hedge funds' portfolios at the end of September. The all time high for this statistics is 23.
DBV - DBV Technologies SA Sustainability | Morningstar
Review DBV Technologies SA (DBV:XMUN) stock and the current sustainability and ESG risk rating to help with your investing decisions.
DBV Technologies (DBVT) Worth a Look: Stock Up 5.7% - Yahoo Finance
DBV Technologies S.A. DBVT was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a ...
DBV Technologies S.A.: DBV Technologies Reports Second Quarter and Half ...
Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT - ...
DBV Technologies S.A.: DBV Technologies to Participate in Upcoming ...
Châtillon, France, October 18, 2024 DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage ...
Here’s What Hedge Funds Think About DBV Technologies SA – ADR (DBVT)
Among these funds, Baker Bros. Advisors held the most valuable stake in DBV Technologies SA – ADR (NASDAQ:DBVT), which was worth $45.3 million at the end of the second quarter.
Why DBV Technologies Is Changing Up Senior Leadership
DBV Technologies S.A. (NASDAQ: DBVT) shares made a handy gain on Thursday after the company announced that it would be making some changes in its senior leadership ahead of its anticipated ...
DBV - DBV Technologies SA Executives | Morningstar
Learn about the executive team and board of directors at DBV Technologies SA (DBV:XSTU) and review their bios and compensation over the latest fiscal years.
DBV Technologies SA (DBVT) Fell Out Of Favor With Hedge Funds
DBV Technologies SA (NASDAQ:DBVT) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for DBVT is 21.
Similar Companies
Loading the latest forecasts...